PCVX VAXCYTE, INC.
Research report · from SEC EDGAR · close 2026-07-13
$57.03 -2.0%
$8.23B mkt cap
executive summary
VAXCYTE, INC. (PCVX) is a $8.23B company. It is not yet profitable. Our health score is B (77/100). 2 red flags on file. Smart money is buying (2 Congress, 1 funds). It funds itself; low dilution risk.
⚠Active dilution shelf
An effective S-3 shelf with 3 prospectus filing(s) in 12 months — shares may be getting sold into the market.
⚠One-sided insider selling
12 insider sales and no open-market buys in the recent window.
who's buying
Insider buys / sells
0 / 12
Cash & ST investments
$1.74B
Operating cash flow
-$655.6M
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.